Treatment of hereditary angioedema with plasma-derived C1 inhibitor
Therapeutics and Clinical Risk Management, 2008 Michael J Prematta, Tracy Prematta, Timothy J CraigSection of Allergy and Immunology, Penn State University, Milton S. Hershey Medical Center, PA, USABackground: Plasma-derived C1 inhibitor (C1-INH) concentrate is a treatment option for acute hereditary ...
Michael J Prematta +2 more
doaj
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence [PDF]
, 2020 Konrad Bork +5 more
openalex +1 more source
Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema [PDF]
, 2016 Alban Deroux +11 more
openalex +1 more source
Management of hereditary angioedema in pediatric, pregnant, and breast-feeding patients: An expert opinion [PDF]
, 2022 Sun Young Yoon +14 more
openalex +1 more source
SUSTAINED REAL-WORLD ATTACK REDUCTIONS FOLLOWING BEROTRALSTAT INITIATION AMONG PATIENTS WITH HEREDITARY ANGIOEDEMA WITHOUT C1-INHIBITOR DEFICIENCY [PDF]
Mark Davis‐Lorton +7 more
openalex +1 more source
Impact Of The Frankfurt HAE Therapy Protocol On Health-Related Quality Of Life (HRQoL) In 50 Patients With Hereditary Angioedema (HAE) [PDF]
, 2009 W. Kreuz +4 more
openalex +1 more source
Managing Hereditary Angioedema in a Three-Generation Family: Danazol’s Promise in Resource-Limited Settings [PDF]
Pradnya M Joshi +6 more
openalex +1 more source
Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families
, 2017 Camila Lopes Veronez +20 more
openalex +1 more source